Assessment of the overall impact of HLA-B dimorphism on the acquisition of or control of HIV-1 infection will need to take into account a number of effects in addition to the contribution of HLA/peptide complex availability and its impact on the NKG2 pathway. This evidence concerns the gene HLA-B and HIV-1 infection.